W. Zeller

发表

Suicide gene therapy of sarcoma cell lines using recombinant adeno-associated virus 2 vectors

F. Wenz, U. Hengge, S. Fruehauf, 2004, Cancer Gene Therapy.

CXCR4 Expression and Treatment with SDF-1α or Plerixafor Modulate Proliferation and Chemosensitivity of Colon Cancer Cells.

D. Heckmann, H. Allgayer, F. Wenz, 2013, Translational oncology.

Overexpression of Caveolin-1 in Lymphoblastoid TK6 Cells Enhances Proliferation After Irradiation with Clinically Relevant Doses

F. Wenz, C. Herskind, P. Maier, 2010, Strahlentherapie und Onkologie.

LDL receptor activity in human leukocyte subtypes: regulation by insulin.

A. Niendorf, H. Nägele, A. Gebhardt, 1997, Clinical biochemistry.

Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks.

F. Wenz, U. Hengge, J. Topaly, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells.

L. Sellner, F. Wenz, J. Kleinschmidt, 2010, Cytotherapy.

Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.

L. Sellner, F. Wenz, J. Kleinschmidt, 2008, Experimental hematology.

Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice.

C. Baum, W. Zeller, S. Fruehauf, 2002, Human gene therapy.

Efficient gene transfer with pseudotyped recombinant adeno-associated viral vectors into human chronic myelogenous leukemia cells

L. Sellner, F. Wenz, J. Kleinschmidt, 2011, Leukemia & lymphoma.

Recombinant adeno-associated virus 2-mediated transfer of the human superoxide-dismutase gene does not confer radioresistance on HeLa cervical carcinoma cells.

F. Wenz, S. Fruehauf, C. Herskind, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cynthia E . Dunbar and Stefan Fruehauf Farastuk Bozorgmehr , Stefanie Laufs , Stephanie E . Sellers , Ingo Roeder , Werner J . Repopulating Cells Transplantation of Multidrug Resistance 1 Retrovirally Transduced Long-Term

C. Dunbar, W. Zeller, 2007 .

Overexpression of Manganese Superoxide Dismutase Does Not Increase Clonogenic Cell Survival Despite Effect on Apoptosis in Irradiated Lymphoblastoid Cells

F. Wenz, S. Fruehauf, C. Herskind, 2011, Radiation research.

of Colon Cancer Induced Gene Expression , Invasion and Chemosensitivity − α SDF-1 The Disparate Twins : A Comparative Study of CXCR 4 and CXCR 7 in

D. Heckmann, H. Allgayer, J. Sleeman, 2014 .

The Disparate Twins: A Comparative Study of CXCR4 and CXCR7 in SDF-1α–Induced Gene Expression, Invasion and Chemosensitivity of Colon Cancer

D. Heckmann, H. Allgayer, J. H. Leupold, 2013, Clinical Cancer Research.

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib

M. Sperandio, F. Wenz, G. Calandra, 2009, Leukemia & lymphoma.

MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions.

M. Grez, B. Schiedlmeier, C. Baum, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

MDR1 Gene Transfer Using a Lentiviral SIN Vector Confers Radioprotection to Human CD34+ Hematopoietic Progenitor Cells

F. Wenz, S. Fruehauf, C. Herskind, 2008, Radiation research.

SNAI2 as a Novel Radioprotector of Normal Tissue by Gene Transfer Using a Lentiviral Bicistronic SIN Vector

F. Wenz, C. Herskind, P. Maier, 2010, Radiation research.

Genetic Vaccines and Therapy

A. Jauch, R. Lockey, L. Sellner, 2008 .

Overexpression of MDR1 Using a Retroviral Vector Differentially Regulates Genes Involved in Detoxification and Apoptosis and Confers Radioprotection

Stefan Fruehauf, Li Li, Christopher Baum, 2006, Radiation research.

Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells.

A. Jauch, A. Ho, A. Benner, 2003, Blood.

Effect of allogeneic blood transfusions on the growth of two different tumours in the rat.

W. Rössler, V. Lenhard, W. Zeller, 1985, Urologia internationalis.

A Lentiviral CXCR4 Overexpression and Knockdown Model in Colorectal Cancer Cell Lines Reveals Plerixafor-Dependent Suppression of SDF-1α-Induced Migration and Invasion

D. Heckmann, H. Allgayer, F. Wenz, 2011, Oncology Research and Treatment.

Normal-Tissue Radioprotection by Overexpression of the Copper-Zinc and Manganese Superoxide Dismutase Genes

L. Sellner, F. Wenz, A. Radujkovic, 2009, Strahlentherapie und Onkologie.

SLUG as a Novel Radioprotector of Normal Tissue by Gene Transfer using a Lentiviral Bicistronic SIN Vector

F. Wenz, C. Herskind, P. Maier, 2009 .

An experimental model for meningeal leukemia in rats (L5222). Effect of treatment with BCNU and cyclophosphamide

H. Fiebig, W. Zeller, D. Schmähl, 1976, International journal of cancer.

The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.

H. Goldschmidt, A. Ho, W. Zeller, 2006, Experimental hematology.

Cold spots in hot spots: transcription start sites of active genes are spared from HIV vector integration

M. Gisslén, L. Else, A. Yilmaz, 2009, AIDS.

Lentiviral vector integration sites in human NOD/SCID repopulating cells

Stefan Fruehauf, Agnes Hotz-Wagenblatt, Guillermo Guenechea, 2006, The journal of gene medicine.

Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells

A. Ho, W. Zeller, A. Radujkovic, 2010, Cancer Chemotherapy and Pharmacology.

Cross‐resistance of imatinib mesylate and 17‐aag in imatinib‐resistant cells that overexpress bcr‐abl

J. Melo, W. Zeller, J. Topaly, 2003, British journal of haematology.

Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors

A. Ho, E. Buchdunger, W. Zeller, 1999, Cancer Chemotherapy and Pharmacology.

CD34 selection for purging in multiple myeloma and analysis of CD34+ b cell precursors

W. Zeller, S. Fruehauf, R. Haas, 1994, Stem cells.